Table 6.
Characteristic | Cases n = 9 |
Controls n = 9 |
P value |
---|---|---|---|
Age, mos., mean (SD) | 27 (16) | 34 (17) | 0.32 |
Female gender, n (%) | 6 (67) | 5 (56) | 0.96 |
Weight, kg, mean (SD) | 11.4 (2.6) | 12 (2.9) | 0.54 |
Net use, n (%) | 9 (100) | 9 (100) | - |
Household indoor residual spraying, n (%) | 9 (100) | 9 (100) | - |
Fever on presentation, n (%) | 2 (22) | 1 (11) | 0.66 |
Anti-malarial use within prior 1 mo., n (%) | 2(22) | 1 (11) | 0.66 |
Parasite density at enrollment, μL−1, median (IQR) | 9,920 (1,640–18,480) | 17,040 (3,640–32,360) | 0.21 |
Time to clearance, h, mean (SD) | 26 (13) | 35 (11) | 0.10 |
Day 7 lumefantrine concentration, ng/ml, mean (SD) | 181 (158) | 235 (276) | 0.64 |
P values were estimated from chi-squared or Student’s t test. For parasite density at enrollment, the log-transformed data were used for statistical testing.
SD, standard deviation. IQR, interquartile range.